TrialClinical and translational medicine2021

Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial.

Xiaowei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.